Pathogenesis of Dementia

Pathogenesis of Dementia

According to Alzheimer’s Disease International, 55 million people worldwide are living with dementia. Dementia is a disorder that manifests as a set of related symptoms, which usually result from the brain being damaged by injury or disease. The symptoms involve progressive impairments in memory, th...

Full description

Bibliographic Details
Main Author:	Janusz Wiesław Błaszczyk
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	International Journal of Molecular Sciences
Subjects:	dementia Alzheimer’s disease brain energy metabolism cognitive metabolism brain aging neurodegenerative disorders
Online Access:	https://www.mdpi.com/1422-0067/24/1/543

Similar Items

Energy Metabolism Decline in the Aging Brain—Pathogenesis of Neurodegenerative Disorders
by: Janusz Wiesław Błaszczyk
Published: (2020-11-01)

Sleep disorders contribute to the development of dementia and Alzheimer’s disease
by: Janusz Wiesław Błaszczyk
Published: (2023-10-01)

Using stable isotope tracing to unravel the metabolic components of neurodegeneration: Focus on neuron-glia metabolic interactions
by: Emil W. Westi, et al.
Published: (2023-06-01)

LC-MS/MS Insight into Vitamin C Restoration to Metabolic Disorder Evoked by Amyloid β in <i>Caenorhabditis elegans</i> CL2006
by: Simeng Zhang, et al.
Published: (2022-09-01)

Dementia in the old age: a gloomy wood later in life
by: Virginia Boccardi, et al.
Published: (2018-11-01)

The Emerging Role of Energy Metabolism and Neuroprotective Strategies in Parkinson's Disease
by: Janusz W. Błaszczyk, et al.
Published: (2018-10-01)

RNA Modifications and RNA Metabolism in Neurological Disease Pathogenesis
by: Biswanath Chatterjee, et al.
Published: (2021-11-01)

Editorial: Physical Activity: Epigenetic and Metabolic Regulation of Brain Aging
by: Simona Daniele, et al.
Published: (2020-07-01)

Assessment of risk factors in dogs with presumptive advanced canine cognitive dysfunction
by: Brittany MacQuiddy, et al.
Published: (2022-10-01)

Aging, lifestyle and dementia
by: Devin Wahl, et al.
Published: (2019-10-01)

Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming
by: Rongrong Han, et al.
Published: (2021-05-01)

Bilingualism for Dementia: Neurological Mechanisms Associated With Functional and Structural Changes in the Brain
by: Sujin Kim, et al.
Published: (2019-11-01)

Women's higher brain metabolic rate compensates for early Alzheimer's pathology
by: Erin E. Sundermann, et al.
Published: (2020-01-01)

"How could neuroimaging be helpful in the assessment of Dementia in a clinical setting? "
by: Malakouti K, et al.
Published: (2002-07-01)

"How could neuroimaging be helpful in the assessment of Dementia in a clinical setting? "
by: Malakouti K, et al.
Published: (2002-09-01)

Distinct changes in brain metabolism in patients with dementia and hearing loss
by: Ji Hyuk Han, et al.
Published: (2024-01-01)

Diagnosing dementia and normal aging: clinical relevance of brain ratios and cognitive performance in a Brazilian sample
by: M.L.F. Chaves, et al.
Published: (1999-09-01)

Nanomedicines in the Management of Alzheimer’s Disease: Current View and Future Prospects
by: Hitesh Chopra, et al.
Published: (2022-07-01)

Cumulative Exposure to Metabolic Syndrome Components and the Risk of Dementia: A Nationwide Population-Based Study
by: Yunjung Cho, et al.
Published: (2021-04-01)

Neuroimaging Biomarkers Predicting the Efficacy of Multimodal Rehabilitative Intervention in the Alzheimer’s Dementia Continuum Pathology
by: Sonia Di Tella, et al.
Published: (2021-11-01)

The Dementia Rating Scale (DRS) in the diagnosis of vascular dementia
by: Cláudia Sellitto Porto, et al.

Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services—part 4 of 6
by: Alina Solomon, et al.
Published: (2021-10-01)

The Role of Acyl-CoA β-Oxidation in Brain Metabolism and Neurodegenerative Diseases
by: Sylwia Szrok-Jurga, et al.
Published: (2023-09-01)

Changes in metabolic risk factors over 10 years and their associations with late‐life cognitive performance: The Multi‐Ethnic Study of Atherosclerosis
by: Timothy M. Hughes, et al.
Published: (2017-01-01)

The fibroblast growth factor system in cognitive disorders and dementia
by: Wujianwen Zhai, et al.
Published: (2023-05-01)

Editorial: Brain Insulin Resistance in Neurodevelopmental and Neurodegenerative Disorders: Mind the Gap!
by: Mara Dierssen, et al.
Published: (2021-08-01)

Application of machine learning in dementia diagnosis: A systematic literature review
by: Gauhar Kantayeva, et al.
Published: (2023-11-01)

Metabolic brain pattern in dementia with Lewy bodies: Relationship to Alzheimer’s disease topography
by: Matej Perovnik, et al.
Published: (2022-01-01)

Dietary Patterns and Alzheimer’s Disease: An Updated Review Linking Nutrition to Neuroscience
by: Ines Ellouze, et al.
Published: (2023-07-01)

Expression of the Excitatory Postsynaptic Scaffolding Protein, Shank3, in Human Brain: Effect of Age and Alzheimer’s Disease
by: Lily Wan, et al.
Published: (2021-08-01)

Novel molecular mechanisms in Alzheimer’s disease: The potential role of DEK in disease pathogenesis
by: Allie N. Greene, et al.
Published: (2022-10-01)

Alzheimer and vascular brain disease: Senile dementia
by: Eliasz Engelhardt, et al.

Impact of Gut Microbiome Lactobacillus spp. in Brain Function and its Medicament towards Alzheimer’s Disease Pathogenesis
by: Shani Kunjamma John, et al.
Published: (2021-09-01)

Review of Current Human Genome-Scale Metabolic Models for Brain Cancer and Neurodegenerative Diseases
by: Ali Kishk, et al.
Published: (2022-08-01)

Editorial: The heart-brain connection in emotions, cognition, and dementia
by: Knut A. Hestad, et al.
Published: (2022-11-01)

Is Alzhezimer’s disease a New Type Diabetes? Crosstalk between two serious disorders: review
by: Maciej Dobosz, et al.
Published: (2023-01-01)

Pharmacogenetics of cerebrovascular metabolism modulators in dementia due to Alzheimer’s disease
by: Fabricio Ferreira de Oliveira
Published: (2015-03-01)

Ketones and brain development: Implications for correcting deteriorating brain glucose metabolism during aging
by: Nugent Scott, et al.
Published: (2016-01-01)

Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6
by: Janice M. Ranson, et al.
Published: (2021-10-01)

Association between choline supplementation and Alzheimer’s disease risk: a systematic review protocol
by: Sixtus Aguree, et al.
Published: (2023-08-01)